Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
98 hedge funds and large institutions have $511M invested in Myovant Sciences Ltd. in 2022 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 22 closing their positions.
38% more capital invested
Capital invested by funds: $369M → $511M (+$142M)
32% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 22
8% more funds holding
Funds holding: 91 → 98 (+7)
4% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 25
27% less call options, than puts
Call options by funds: $9.92M | Put options by funds: $13.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$31.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$3.23M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$2.06M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.9M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$23.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$15.2M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$9.54M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.19M |
| 5 |
Millennium Management
New York
|
-$4.02M |
MYOV Hedge Fund Activity: Q3 2022 in Review
98 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q3 2022, worth a combined $511M — up 38% from $369M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new MYOV positions and 22 closed out — a net gain of 7 holders — while 26 added to existing stakes and 25 trimmed.
The largest buyer was Polar Capital Holdings, opening a new position worth an estimated $31.1M. The largest seller was Janus Henderson Group, cutting an estimated $23.9M.
- 98 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q3 2022, up from 91 in Q2 2022.
- Funds reported $511M of Myovant Sciences Ltd. stock for Q3 2022, up 38% quarter-over-quarter.
- 29 funds opened new Myovant Sciences Ltd. positions in Q3 2022 and 22 closed out, a net change of +7 holders.
- The largest Myovant Sciences Ltd. buyer in Q3 2022 was Polar Capital Holdings, an estimated $31.1M added.
- The largest Myovant Sciences Ltd. seller in Q3 2022 was Janus Henderson Group, an estimated $23.9M sold.
Based on aggregated 13F filings for Q3 2022.